[1]周 欣,张启鑫.加味二陈汤联合西药治疗老年社区获得性肺炎痰湿阻肺证的临床观察[J].医学信息,2025,38(08):127-130,135.[doi:10.3969/j.issn.1006-1959.2025.08.026]
　ZHOU Xin,ZHANG Qixin.Clinical Observation of Modified Erchen Decoction Combined with Western Medicine in the Treatment of Elderly Community Acquired Pneumonia with Syndrome of Phlegm-damp Obstructing Lung[J].Journal of Medical Information,2025,38(08):127-130,135.[doi:10.3969/j.issn.1006-1959.2025.08.026]
点击复制

加味二陈汤联合西药治疗老年社区获得性肺炎痰湿阻肺证的临床观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年08期
页码:
127-130,135
栏目:
论著
出版日期:
2025-04-15

文章信息/Info

Title:
Clinical Observation of Modified Erchen Decoction Combined with Western Medicine in the Treatment of Elderly Community Acquired Pneumonia with Syndrome of Phlegm-damp Obstructing Lung
文章编号:
1006-1959（2025）08-0127-05
作者:
周 欣; 张启鑫
乐平市中医医院急诊科，江西 乐平 333300
Author(s):
ZHOU Xin;  ZHANG Qixin
Department of Emergency, Leping Hospital of Traditional Chinese Medicine, Leping 333300, Jiangxi, China
关键词:
加味二陈汤; 西药治疗; 老年社区获得性肺炎; 痰湿阻肺证
Keywords:
Modified Erchen decoction;  Western medicine treatment;  Community-acquired pneumonia in the elderly;  Syndrome of phlegm-damp obstructing lung
分类号:
R563.1
DOI:
10.3969/j.issn.1006-1959.2025.08.026
文献标志码:
A
摘要:
目的 观察加味二陈汤联合西药治疗老年社区获得性肺炎痰湿阻肺证的临床疗效。方法 选取2022年1月-2024年3月乐平市中医医院接受治疗的痰湿阻肺型老年社区获得性肺炎患者64例为研究对象，按照随机数字表法分为对照组和研究组，各32例。对照组应用常规西药治疗，研究组在对照组基础上应用加味二陈汤治疗。比较两组临床疗效、症状消除时间（咳嗽消失时间、气促消失时间、炎症吸收时间、体温恢复正常时间、啰音消失时间）、炎性细胞[降钙素原（PCT）、中性粒细胞比值（NEUT%）、白细胞计数（WBC）、C-反应蛋白（CRP）]水平、中医证候（咳嗽、发热、咳痰、胸闷、乏力）积分。结果 与对照组治疗总有效率的75.00%比较，研究组治疗总有效率更高，达96.88%（P＜0.05）；与对照组比较，研究组咳嗽消失时间、气促消失时间、炎症吸收时间、体温恢复正常时间、啰音消失时间更短（P＜0.05）；与治疗前比较，两组治疗后WBC、NEUT%、CRP、PCT水平均降低，且与对照组比较，研究组治疗后WBC、NEUT%、CRP、PCT水平更低（P＜0.05）；与治疗前比较，两组治疗后中医症候各积分均降低，且与对照组比较，研究组治疗后中医症候各积分更低（P＜0.05）。结论 加味二陈汤联合西药治疗老年社区获得性肺炎痰湿阻肺证的临床疗效确切，能够加快临床症状改善速度，减轻炎症反应，值得临床应用。
Abstract:
Objective To observe the clinical effect of modified Erchen decoction combined with western medicine in the treatment of elderly community-acquired pneumonia with syndrome of phlegm-damp obstructing lung. Methods A total of 64 elderly community-acquired pneumonia patients with syndrome of phlegm-damp obstructing lung who were treated in Leping Hospital of Traditional Chinese Medicine from January 2022 to March 2024 were selected as the research objects. According to the random number table method, they were divided into control group and study group, with 32 patients in each group. The control group was treated with conventional western medicine, and the study group was treated with modified Erchen decoction on the basis of the control group. The clinical efficacy, symptom elimination time (cough disappearance time, shortness of breath disappearance time, inflammation absorption time, body temperature recovery time, rale disappearance time), inflammatory cells [procalcitonin (PCT), neutrophil ratio (NEUT%), white blood cell count (WBC), C-reactive protein (CRP)] levels, and TCM syndromes (cough, fever, expectoration, chest tightness, fatigue) scores were compared between the two groups. Results Compared with 75.00% of the total effective rate of the control group, the total effective rate of the study group was higher, reaching 96.88% (P<0.05). Compared with the control group, the disappearance time of cough, the disappearance time of shortness of breath, the absorption time of inflammation, the recovery time of body temperature and the disappearance time of rales in the study group were shorter (P<0.05). Compared with before treatment, the levels of WBC, NEUT%, CRP and PCT in the two groups decreased after treatment, and compared with the control group, the levels of WBC, NEUT%, CRP and PCT in the study group were lower after treatment (P<0.05). Compared with before treatment, the scores of TCM symptoms in the two groups decreased after treatment, and compared with the control group, the scores of TCM symptoms in the study group were lower after treatment (P<0.05). Conclusion Modified Erchen decoction combined with western medicine has a definite clinical effect in the treatment of elderly community-acquired pneumonia patients with syndrome of phlegm-damp obstructing lung, which can accelerate the improvement of clinical symptoms and reduce inflammatory response. It is worthy of clinical application.

参考文献/References:

[1]马海霞,廖媛嫔,阳扬,等.火龙罐疗法治疗社区获得性肺炎（痰湿阻肺证）患者临床观察[J].中国中医急症,2023,32(12):2138-2141.[2]张晨曦,关胜男,谢凯,等.重症社区获得性肺炎患者中医临床证候分布规律研究[J].中国全科医学,2022,25(21):2640-2645.[3]胡跃强,卢健棋,黄进,等.基于桂枝二陈汤的“三焦次第疗法”治疗新型冠状病毒肺炎临床观察[J].中华中医药学刊,2020,38(10):1-5.[4]殷霁虹,符德玉.加味二陈汤联合阿托伐他汀对痰湿阻遏型高脂血症患者炎症因子、尿酸、颈动脉斑块的影响[J].中国中医药科技,2022,29(4):528-532.[5]洪小兵,蒋梦霞,陈永青.加味二陈汤治联合西药治疗稳定期慢性阻塞性肺疾病临床研究[J].新中医,2021,53(6):17-20.[6]胡文豪,尚立芝,谢文英,等.基于Midkine/Notch2/Hey1信号通路探讨二陈汤加味对慢性阻塞性肺疾病大鼠的抗炎作用[J].中国实验方剂学杂志,2023,29(16):12-21.[7]吴珂,尚立芝,谢文英,等.二陈汤加味对慢性阻塞性肺疾病细支气管壁细胞外基质重塑的影响[J].中国实验方剂学杂志,2018,24(14):122-127.[8]张琼,沙媛媛,范倩,等.加味宣白承气汤治疗痰热壅肺型老年社区获得性肺炎临床疗效及对免疫功能的影响[J].天津中医药,2023,40(6):709-714.[9]李志尚,蔡海荣,张为章,等.宣白承气汤加味治疗老年社区获得性肺炎的临床研究[J].中国中医急症,2019,28(6):965-968.[10]黎荣立,王祖棣.加味二陈汤联合抗生素治疗痰湿阻肺型肺炎的临床效果[J].中外医学研究,2020,18(8):122-123.[11]狄冠麟,朱振刚,郑延龙.越婢加半夏汤对老年社区获得性肺炎痰热壅肺证及对炎性标志物预后的影响[J].中国实验方剂学杂志,2020,26(22):59-64.[12]华胜毅,芮庆林.银翘白虎汤治疗老年社区获得性肺炎痰热壅肺证临床观察[J].四川中医,2018,36(8):60-62.[13]韩金花,刘洋,郑彩霞,等.清瘟解毒汤联合机械通气治疗老年重症社区获得性肺炎临床研究[J].国际中医中药杂志,2020,42(12):1107-1111.[14]梁慧.自拟清肺化痰汤治疗老年社区获得性肺炎的效果观察[J].中国中医药科技,2022,29(2):342-343.[15]张琼,钱义明.宣白承气汤治疗老年社区获得性肺炎痰热壅肺型的临床观察[J].河北中医,2018,40(9):1316-1320,1325.[16]陈乾,蒋锦琪,熊旭东.清热益肺汤联合注射用头孢西丁钠治疗中度老年社区获得性肺炎临床观察[J].河北中医,2018,40(11):1691-1696.[17]詹坤鹏.加味二陈汤治疗痰瘀阻肺型AECOPD的疗效及凝血影响[D].广州:广州中医药大学,2023.[18]汤守香,马静,薛尧,等.N-乙酰半胱氨酸联合左氧氟沙星治疗老年社区获得性肺炎临床疗效及对炎症因子水平的影响[J].中国煤炭工业医学杂志,2018,21(6):599-603.[19]刘疆豪,蒋红生,赵华东,等.十五味清热化痰汤联合莫西沙星治疗社区获得性肺炎的疗效观察[J].中国中医药科技,2020,27(1):89-91.

相似文献/References:

[1]牛春生.慢性鼻窦炎的治疗研究[J].医学信息,2020,33(04):59.[doi:10.3969/j.issn.1006-1959.2020.04.018]
　NIU Chun-sheng.Study on the Treatment of Chronic Sinusitis[J].Journal of Medical Information,2020,33(08):59.[doi:10.3969/j.issn.1006-1959.2020.04.018]
[2]陈 鑫,李 虹,周绍鹏,等.加味二陈汤辨证治疗小儿咳嗽的临床疗效观察[J].医学信息,2022,35(18):135.[doi:10.3969/j.issn.1006-1959.2022.18.037]
　CHEN Xin,LI Hong,ZHOU Shao-peng,et al.Clinical Observation on Treatment of Infantile Cough with Jiawei Erchen Decoction[J].Journal of Medical Information,2022,35(08):135.[doi:10.3969/j.issn.1006-1959.2022.18.037]
[3]雷画星.加味二陈汤联合化疗治疗非小细胞肺癌的效果观察[J].医学信息,2024,37(02):132.[doi:10.3969/j.issn.1006-1959.2024.02.026]
　LEI Hua-xing.Effect Observation of Jiawei Erchen Decoction Combined with Chemotherapy in the Treatment of Non-small Cell Lung Cancer[J].Journal of Medical Information,2024,37(08):132.[doi:10.3969/j.issn.1006-1959.2024.02.026]

更新日期/Last Update: 1900-01-01